SMAD4 and cancer: Our results revealed dignificant differences in mutation frequencies of certain genes between duodenum and jejunum/ileum cancers, specifically in APC, SMAD4, CDKN2A, PIK3CA, etc. This observation suggests that the varying responses to treatment in relation to mutated genes could potentially account for the heterogeneous clinical outcomes.